As of 2025-07-06, the EV/EBITDA ratio of AtriCure Inc (ATRC) is -184.02. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AtriCure's latest enterprise value is 1,535.32 mil USD. AtriCure's TTM EBITDA according to its financial statements is -8.34 mil USD. Dividing these 2 quantities gives us the above AtriCure EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.2x - 17.5x | 15.6x |
| Forward P/E multiples | 21.3x - 26.8x | 24.9x |
| Fair Price | (2.85) - (2.21) | (2.67) |
| Upside | -109.0% - -106.9% | -108.4% |
| Date | EV/EBITDA |
| 2025-07-03 | -184.02 |
| 2025-07-02 | -181.83 |
| 2025-07-01 | -186.63 |
| 2025-06-30 | -190.02 |
| 2025-06-27 | -187.11 |
| 2025-06-26 | -190.67 |
| 2025-06-25 | -187.05 |
| 2025-06-24 | -189.84 |
| 2025-06-23 | -184.85 |
| 2025-06-20 | -181.89 |
| 2025-06-18 | -183.13 |
| 2025-06-17 | -189.01 |
| 2025-06-16 | -187.29 |
| 2025-06-13 | -183.19 |
| 2025-06-12 | -187.41 |
| 2025-06-11 | -191.50 |
| 2025-06-10 | -193.70 |
| 2025-06-09 | -198.38 |
| 2025-06-06 | -202.89 |
| 2025-06-05 | -202.48 |
| 2025-06-04 | -202.77 |
| 2025-06-03 | -201.65 |
| 2025-06-02 | -197.31 |
| 2025-05-30 | -200.70 |
| 2025-05-29 | -197.79 |
| 2025-05-28 | -194.59 |
| 2025-05-27 | -197.26 |
| 2025-05-23 | -189.66 |
| 2025-05-22 | -190.25 |
| 2025-05-21 | -192.92 |
| 2025-05-20 | -197.61 |
| 2025-05-19 | -187.82 |
| 2025-05-16 | -189.66 |
| 2025-05-15 | -187.23 |
| 2025-05-14 | -186.93 |
| 2025-05-13 | -182.36 |
| 2025-05-12 | -184.32 |
| 2025-05-09 | -179.46 |
| 2025-05-08 | -180.58 |
| 2025-05-07 | -175.42 |
| 2025-05-06 | -172.69 |
| 2025-05-05 | -168.06 |
| 2025-05-02 | -173.70 |
| 2025-05-01 | -169.37 |
| 2025-04-30 | -173.05 |
| 2025-04-29 | -201.17 |
| 2025-04-28 | -195.36 |
| 2025-04-25 | -193.75 |
| 2025-04-24 | -195.83 |
| 2025-04-23 | -188.36 |